Multiple sclerosis: emerging epidemiological trends and redefining the clinical course
University of Florence · Copenhagen University Hospital · +12 more institutions
Abstract
Multiple sclerosis is a chronic, inflammatory, and neurodegenerative disease of the central nervous system and a major cause of neurological disability in young adults. Its prevalence and incidence are increasing, and it has been estimated at over 2.8 million cases worldwide, in addition to recent trends towards a shift in MS prevalence to older ages, with peak prevalence estimates in the sixth decade of life. Although historically the relapsing and progressive phases of the disease have been considered separate clinical entities, recent evidence of progression independent of relapse activity (PIRA) has led to a reconsideration of multiple sclerosis as a continuum, in which relapsing and progressive features…
Citation impact
- FWCI
- 47.00
- Percentile
- 100%
- References
- 156
Authors
10- EPEmilio PortaccioCorresponding
University of Florence
- MMMelinda Magyari
Copenhagen University Hospital, Rigshospitalet, Danish Multiple Sclerosis Center
- EHEva Havrdová
Charles University
- ARAurélie Ruet
Université de Bordeaux, Inserm, Centre Hospitalier Universitaire de Bordeaux, Observatoire Français de la Sclérose en Plaques, Neurocentre Magendie
- BBBruno Brochet
Université de Bordeaux, Inserm, Neurocentre Magendie
Topics & keywords
- Disease
- Epidemiology
- Multiple sclerosis
- Medicine
- Clinical epidemiology
- Life course approach
- Clinical disease
- Intensive care medicine
- Good health and well-being
Funding
- NMNational Multiple Sclerosis Society
- BSBristol-Myers Squibb
- SSanofi
- BBiogen
- TPTeva Pharmaceutical Industries
- APAlexion Pharmaceuticals
- CCelgene
- MKMerck KGaA
- TTTG Therapeutics
- MMylan
- MModerna
- MDMinisterio de Ciencia e InnovaciónAwards: 100010434, ID 100010434
- MSMultiple Sclerosis International Federation
- SHSiemens Healthineers
- FBFundación Bancaria Caixa d'Estalvis i Pensions de BarcelonaAwards: LCF/BQ/PI20/11760008, ID 100010434, 100010434
- ESEMD Serono
- SGSanofi Genzyme
- IDInstituto de Salud Carlos IIIAwards: FORT23, FORT23/00034
- JPJanssen Pharmaceuticals